Development of Oro-Dispersible Tablet of Meclizine by Using Different Superdisintegrating Agents
Abstract
The proposed study is development of oro-dispersible tablet containing meclizine hydrochloride solid dispersion (FMODDs) formulation with using natural superdisintegrant with direct compression. The superdisintegrants and its concentration shall be during the preparation of FMODDs with meclizine hydrochloride by using direct compression via employing different excipients in different ratio including: superdisintegrants {sodium starch glycolate (SSG), Ac-Di-Sol, crosspovidone (CP), Spray dried lactose and microcrystalline cellulose (MCC)} which were used alone and in various combination and mannitol, along with lubricant and glidants. The object of proposed work was preparation of FMODDs with a short disintegration time, sufficient mechanical strength, better patient compliance, and acceptable stability profile by employing different methods of preparation and studying different variables affecting pre and post-compression parameters of formulas of meclizine hydrochloride. The combination of agents have more disintegrating property due to rapid water uptake and dispersion time which lead to rapid release of drug and made the dissolution faster. The results of the release kinetics study showed that all the formulations obeyed first order drug release profile more closely, i.e., the release rate depended upon the initial concentration of drug.
Keywords: Solid dispersion, Oro-dispersible, Fast disintegration, Direct compressed tablet, Meclizine hydrochloride, Superdisintegranting agents
Keywords:
Solid dispersion, Oro-dispersible, Fast disintegration, Direct compressed tablet, Meclizine hydrochloride, Superdisintegranting agentsDOI
https://doi.org/10.22270/jddt.v12i4.5413References
Pandya P, Gattani S, Jain P, Surana S, "Co-solvent Evaporation method for enhancement of solubility & dissolution rate of poorly aqueous soluble drug Simvastatin : In vitro-in vivo evaluation", AAPS Pharmascitech, 2008; 9: 1247-1248. https://doi.org/10.1208/s12249-008-9176-z
Wehling F, Steve S, Navayanarao M, 1993, Pediatric effervescent dosage form. US Patent 5223264.
Sohi H, Sultana Y, Khar RK, "Taste Masking Technologies in Oral Pharmaceuticals: Recent Developments and Approaches", Drug Development and Industrial Pharmacy, 2004; 30:429-448. https://doi.org/10.1081/DDC-120037477
Parkash V, Maan S, Deepika, Yadav SK, Hemlata, Jogpal V. Fast disintegrating tablets: Opportunity in drug delivery system. J Adv Pharm Technol Res. 2011; 2(4):223-235. https://doi.org/10.4103/2231-4040.90877
Hannan PA, Khan JA, Khan A, Safiullah S. Oral Dispersible System: A New Approach in Drug Delivery System. Indian J Pharm Sci. 2016; 78(1):2-7. https://doi.org/10.4103/0250-474X.180244
Pawar H, Varkhade C, Jadhav P, Mehra K, Development and evaluation of orodispersible tablets using a natural polysaccharide isolated from Cassia tora seeds, Integrative Medicine Research, 2014; 3:91-98. https://doi.org/10.1016/j.imr.2014.03.002
Elkhodairy KA, Hassan MA, Afifi SA, Formulation and optimization of orodispersible tablets of flutamide, Saudi Pharmaceutical Journal, 2014; 22:53-61. https://doi.org/10.1016/j.jsps.2013.01.009
Zhao Y, Quan P, Fang L, Preparation of an oral thin film containing meclizine hydrochloride: In vitro and in vivo evaluation, International Journal of Pharmaceutics, 2015; 496:314-322. https://doi.org/10.1016/j.ijpharm.2015.10.008
Madgulkar A, Bandivadekar M, Shid T, Rao S. Sugars as solid dispersion carrier to improve solubility and dissolution of the BCS class II drug: clotrimazole. Drug Development and Industrial Pharmacy, 2015; 23:1-11. https://doi.org/10.3109/03639045.2015.1024683
Oliveira LJ, Veiga A, Stofella NCF, Cunha AC, da Graça T Toledo M, Andreazza IF, Murakami FS. Development and Evaluation of Orodispersible Tablets Containing Ketoprofen. Curr Drug Deliv. 2020; 17(4): 348-360. https://doi.org/10.2174/1567201817666200317122807
Published
Abstract Display: 505 
PDF Downloads: 503 PDF Downloads: 91 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.